CLO26-107: A Meta-Analysis and Network Meta-Analysis for Overall Survival of Pembrolizumab Monotherapy Versus Combined With Chemotherapy as First-Line Therapy in No EGFR/ALK-Mutation Advanced or Metastatic Non-Small-Cell Lung Cancer